Koumakis, George <br/><br/>
Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Mar 2002 
 - 315-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/s0169-5002(01)00441-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Survival Rate<br/>Time Factors